首页> 外国专利> DETECTION OF HUMAN α-THALASSEMIA MUTATIONS AND THEIR USE AS PREDICTORS OF BLOOD-RELATED DISORDERS

DETECTION OF HUMAN α-THALASSEMIA MUTATIONS AND THEIR USE AS PREDICTORS OF BLOOD-RELATED DISORDERS

机译:人体α-地中海贫血突变的检测及其在与血液有关的疾病中的预测作用

摘要

The invention is based on the discovery that adults having a genotype comprising a hemoglobin α-gene deletion are significantly more likely to be hypertensive than adults having a normal (αα/αα) genotype. The invention provides an improved method for determining a human subject's genotype at the α-gene loci; a method of screening a human subject for an increased potential of developing hypertension and other blood-related disorders; and provides an apparatus/kit for screening a human subject for a risk of developing hypertension and other blood-related disorders.
机译:本发明基于以下发现:具有包括血红蛋白α基因缺失的基因型的成年人比具有正常(αα/αα)基因型的成年人显着更有可能患有高血压。本发明提供了一种改进的方法,用于在α基因位点确定人类受试者的基因型。一种筛选人类受试者发生高血压和其他与血液有关的疾病的可能性增加的方法;并提供了用于对人类受试者进行高血压和其他与血液相关的疾病发展风险筛查的设备/套件。

著录项

  • 公开/公告号WO9716568A1

    专利类型

  • 公开/公告日1997-05-09

    原文格式PDF

  • 申请/专利权人 BOWIE LEMUEL J.;

    申请/专利号WO1996US17565

  • 发明设计人 BOWIE LEMUEL J.;

    申请日1996-10-30

  • 分类号C12Q1/68;C07H21/04;

  • 国家 WO

  • 入库时间 2022-08-22 03:21:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号